The store will not work correctly when cookies are disabled.
6-(4-Chlorophenyl)-2-phenylimidazo[1,2-a]pyridine
ID: ALA4519005
PubChem CID: 58880630
Max Phase: Preclinical
Molecular Formula: C19H13ClN2
Molecular Weight: 304.78
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Clc1ccc(-c2ccc3nc(-c4ccccc4)cn3c2)cc1
Standard InChI: InChI=1S/C19H13ClN2/c20-17-9-6-14(7-10-17)16-8-11-19-21-18(13-22(19)12-16)15-4-2-1-3-5-15/h1-13H
Standard InChI Key: KSTAYRGPKSHZDI-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
22.2815 -1.4940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2803 -2.3136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9884 -2.7225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6981 -2.3131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6952 -1.4904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9866 -1.0852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4029 -2.7198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4028 -3.5381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1103 -3.9455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1064 -2.3106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8145 -2.7143 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.8215 -3.5328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6021 -3.7792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.0776 -3.1128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5908 -2.4548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8934 -3.1041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3075 -3.8099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1239 -3.8032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5272 -3.0915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1082 -2.3850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2931 -2.3951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5737 -1.0856 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 2 0
9 12 1 0
11 10 1 0
10 7 2 0
4 7 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 11 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
14 16 1 0
1 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 304.78 | Molecular Weight (Monoisotopic): 304.0767 | AlogP: 5.32 | #Rotatable Bonds: 2 |
Polar Surface Area: 17.30 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 5.40 | CX LogP: 5.04 | CX LogD: 5.04 |
Aromatic Rings: 4 | Heavy Atoms: 22 | QED Weighted: 0.49 | Np Likeness Score: -1.62 |
References
1. Quattrini L, Gelardi ELM, Coviello V, Sartini S, Ferraris DM, Mori M, Nakano I, Garavaglia S, La Motta C.. (2020) Imidazo[1,2-a]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells., 63 (9): [PMID:32223240] [10.1021/acs.jmedchem.9b01910] |